ZEDIRA
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Roesslerstrasse 83, Darmstadt, Hessen, 6...Phone Number
+49 6151325100Website
www.zedira.comRevenue
<$5 MillionIndustry
About ZEDIRA
Is ZEDIRA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ZEDIRA had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ZEDIRA launches new products
Website visits: Recent activity has been detected on your website
Check out if ZEDIRA is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ZEDIRA
Earning: See what the market has to say on ZEDIRA recently announced quarterly report
Check if ZEDIRA has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ZEDIRA has new funding data
ZEDIRA, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
ZEDIRA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ZEDIRA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ZEDIRA.
ZEDIRA Tech Stack
A closer look at the technologies used by ZEDIRA
ZEDIRA News & Media
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ZEDIRA
Zedira GmbH specializes in the development of innovative therapies for celiac disease, including the first-in-class tissue transglutaminase inhibitor ZED1227. The company also offers microbial transglutaminase for site-specific protein conjugation and is involved in various clinical studies and collaborations to advance treatments for related condi... Read More